Healthcare‑focused AI firm Hippocratic AI secured $126 million in a recent funding round, lifting its valuation to approximately $3.5 b. The company aims to integrate generative‑AI models into medical‑diagnostic workflows and partner with healthcare systems globally. Investors such as Avenir Growth and General Catalyst joined the round, signalling confidence in the convergence of AI and health. The funding comes amid rising demand for AI‑enabled healthcare solutions and an increasing willingness to invest in firms that translate algorithmic innovations into clinical impact.